BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25292154)

  • 1. Inflammation markers and incident venous thromboembolism: the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort.
    Olson NC; Cushman M; Lutsey PL; McClure LA; Judd S; Tracy RP; Folsom AR; Zakai NA
    J Thromb Haemost; 2014 Dec; 12(12):1993-2001. PubMed ID: 25292154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein, obesity, and the risk of arterial and venous thrombosis.
    Horvei LD; Grimnes G; Hindberg K; Mathiesen EB; Njølstad I; Wilsgaard T; Brox J; Braekkan SK; Hansen JB
    J Thromb Haemost; 2016 Aug; 14(8):1561-71. PubMed ID: 27208592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association and Pathways between Dietary Manganese Intake and Incident Venous Thromboembolism.
    Huang Y; Zhang Y; Yang S; Xiang H; Zhou C; Ye Z; Liu M; He P; Zhang Y; Gan X; Qin X
    Thromb Haemost; 2024 Jun; 124(6):546-554. PubMed ID: 37984403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inverse association between serum albumin and future risk of venous thromboembolism: interrelationship with high sensitivity C-reactive protein.
    Kunutsor SK; Seidu S; Katechia DT; Laukkanen JA
    Ann Med; 2018 May; 50(3):240-248. PubMed ID: 29448840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms and mitigating factors for venous thromboembolism in chronic kidney disease: the REGARDS study.
    Cheung KL; Zakai NA; Callas PW; Howard G; Mahmoodi BK; Peralta CA; Judd SE; Kurella Tamura M; Cushman M
    J Thromb Haemost; 2018 Sep; 16(9):1743-1752. PubMed ID: 29984467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum C-reactive protein increases the risk of venous thromboembolism: a prospective study and meta-analysis of published prospective evidence.
    Kunutsor SK; Seidu S; Blom AW; Khunti K; Laukkanen JA
    Eur J Epidemiol; 2017 Aug; 32(8):657-667. PubMed ID: 28718029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. American Heart Association's Life's Simple 7 and risk of venous thromboembolism: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study.
    Olson NC; Cushman M; Judd SE; McClure LA; Lakoski SG; Folsom AR; Safford MM; Zakai NA
    J Am Heart Assoc; 2015 Feb; 4(3):e001494. PubMed ID: 25725088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measures of Kidney Disease and the Risk of Venous Thromboembolism in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study.
    Cheung KL; Zakai NA; Folsom AR; Kurella Tamura M; Peralta CA; Judd SE; Callas PW; Cushman M
    Am J Kidney Dis; 2017 Aug; 70(2):182-190. PubMed ID: 28126238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Decreased Serum Albumin With Risk of Venous Thromboembolism and Mortality in Cancer Patients.
    Königsbrügge O; Posch F; Riedl J; Reitter EM; Zielinski C; Pabinger I; Ay C
    Oncologist; 2016 Feb; 21(2):252-7. PubMed ID: 26764252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial and regional differences in venous thromboembolism in the United States in 3 cohorts.
    Zakai NA; McClure LA; Judd SE; Safford MM; Folsom AR; Lutsey PL; Cushman M
    Circulation; 2014 Apr; 129(14):1502-9. PubMed ID: 24508826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum C-reactive protein-to-albumin ratio may be a potential risk indicator for venous thromboembolism: Findings from a prospective cohort study.
    Kunutsor SK; Kurl S; Voutilainen A; Laukkanen JA
    Nutr Metab Cardiovasc Dis; 2023 Apr; 33(4):864-867. PubMed ID: 36740560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of vitamin D are not associated with future risk of venous thromboembolism. The Tromsø Study.
    Brodin E; Lerstad G; Grimnes G; Brækkan SK; Vik A; Brox J; Svartberg J; Jorde R; Hansen JB
    Thromb Haemost; 2013 May; 109(5):885-90. PubMed ID: 23446951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dynamic changes of inflammation-related indices in venous thromboembolism and the association between these indices and venous thromboembolism].
    Liu FF; Zhai ZG; Yang YH; Wang J; Wang C
    Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(24):1860-3. PubMed ID: 24124734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous thrombosis, thromboembolism, biomarkers of inflammation, and coagulation in coronavirus disease 2019.
    Thondapu V; Montes D; Rosovsky R; Dua A; McDermott S; Lu MT; Ghoshhajra B; Hoffmann U; Gerhard-Herman MD; Hedgire S
    J Vasc Surg Venous Lymphat Disord; 2021 Jul; 9(4):835-844.e4. PubMed ID: 33188961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome and risk of venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology.
    Steffen LM; Cushman M; Peacock JM; Heckbert SR; Jacobs DR; Rosamond WD; Folsom AR
    J Thromb Haemost; 2009 May; 7(5):746-51. PubMed ID: 19175496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemostatic factors, inflammatory markers, and risk of incident venous thromboembolism: The Multi-Ethnic Study of Atherosclerosis.
    Evensen LH; Folsom AR; Pankow JS; Hansen JB; Allison MA; Cushman M; Lutsey PL
    J Thromb Haemost; 2021 Jul; 19(7):1718-1728. PubMed ID: 33773045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance and risk of venous thromboembolism: results of a population-based cohort study.
    Van Schouwenburg IM; Mahmoodi BK; Veeger NJ; Bakker SJ; Kluin-Nelemans HC; Meijer K; Gansevoort RT
    J Thromb Haemost; 2012 Jun; 10(6):1012-8. PubMed ID: 22443091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular Risk Factors Associated With Venous Thromboembolism.
    Gregson J; Kaptoge S; Bolton T; Pennells L; Willeit P; Burgess S; Bell S; Sweeting M; Rimm EB; Kabrhel C; Zöller B; Assmann G; Gudnason V; Folsom AR; Arndt V; Fletcher A; Norman PE; Nordestgaard BG; Kitamura A; Mahmoodi BK; Whincup PH; Knuiman M; Salomaa V; Meisinger C; Koenig W; Kavousi M; Völzke H; Cooper JA; Ninomiya T; Casiglia E; Rodriguez B; Ben-Shlomo Y; Després JP; Simons L; Barrett-Connor E; Björkelund C; Notdurfter M; Kromhout D; Price J; Sutherland SE; Sundström J; Kauhanen J; Gallacher J; Beulens JWJ; Dankner R; Cooper C; Giampaoli S; Deen JF; Gómez de la Cámara A; Kuller LH; Rosengren A; Svensson PJ; Nagel D; Crespo CJ; Brenner H; Albertorio-Diaz JR; Atkins R; Brunner EJ; Shipley M; Njølstad I; Lawlor DA; van der Schouw YT; Selmer RM; Trevisan M; Verschuren WMM; Greenland P; Wassertheil-Smoller S; Lowe GDO; Wood AM; Butterworth AS; Thompson SG; Danesh J; Di Angelantonio E; Meade T;
    JAMA Cardiol; 2019 Feb; 4(2):163-173. PubMed ID: 30649175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum albumin and risk of venous thromboembolism.
    Folsom AR; Lutsey PL; Heckbert SR; Cushman M
    Thromb Haemost; 2010 Jul; 104(1):100-4. PubMed ID: 20390234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White blood cell count measured prior to cancer development is associated with future risk of venous thromboembolism--the Tromsø study.
    Blix K; Jensvoll H; Brækkan SK; Hansen JB
    PLoS One; 2013; 8(9):e73447. PubMed ID: 24023876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.